Recombinant Human B7-H4-Fc Chimera (carrier-free)

Pricing & Availability
Regulatory Status
RUO
Other Names
B7 Homolog 4, B7 Superfamily Member 1 (B7S1), Immune Costimulatory Protein B7-H4 (B7-H4), V-Set Domain Containing T Cell Activation Inhibitor 1 (VCTN1), T Cell Costimulatory Molecule B7x (B7X)
Ave. Rating
Submit a Review
Product Citations
publications
Human_B7-H4_FcChimera_CF_1_062218
Human recombinant B7-H4 inhibits the anti CD3-induced proliferation of activated human T cells.
  • Human_B7-H4_FcChimera_CF_1_062218
    Human recombinant B7-H4 inhibits the anti CD3-induced proliferation of activated human T cells.
  • Human_B7-H4_FcChimera_CF_2_062218
    Stability testing for human B7- H4. Human B7- H4 was aliquoted in PBS at 0.2 mg/ml; one aliquot was kept at 4°C (control) and another was freeze-thawed four times (4 x freeze-thaws). After this procedure, the samples were tested by inhibition of anti CD3-induced proliferation of human activated T cells.
Cat # Size Price Quantity Check Availability Save
774608 500 µg 1172 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
774602 10 µg 89 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
774604 25 µg 141 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
774606 100 µg 364 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote

Select size of product is eligible for a 40% discount! Promotion valid until December 31, 2024. Exclusions apply. To view full promotion terms and conditions or to contact your local BioLegend representative to receive a quote, visit our webpage.

Description

Human and mouse B7-H4 were identified by homology search in mouse and human EST databases;  B7h and B7-H3 amino acid sequences were used for the  screening.  B7-H4 contains one immunoglobulin (Ig) Ig-like V and one Ig-like C domain in the extracellular domain, a transmembrane domain, and an intracellular domain. B7-H4 is expressed in antigen presented cell (APC), and its expression is downregulated in B cells after different stimulus (LPS, IL-4, anti-IgM, and anti-CD40). B7-H4 inhibits cell-cycle progression, proliferation, and cytokine production in CD4 and CD8 T cells. Experimental interference of B7-H4 signaling exacerbates autoimmune diseases such as rheumatoid arthritis and multiple sclerosis. In Type 1 diabetes (T1D) the presence of activated islet-specific T cells is the key feature of the associated autoimmune condition. B7-H4-Ig fusion protein inhibits the proliferation of islet-specific T1D T cell clones obtained from patients. In addition, T1D is considerably reduced in diabetes-susceptible NOD mice treated with B7-H4-Ig protein. High levels in sera of soluble B7-H4 have been detected patients with T1D. The metalloproteinase nardilysin (NRD1) was identified as the enzyme that mediates B7-H4 shedding and the potential cleavage site was described as K246 RRS249. B7-H4 is overexpressed in human cancers and frequently associated with negative clinical outcome. B7-H4 chimeric antigen receptor (CAR) T cell therapy was applied in a mouse model; B7-H4 CAR T cells lysed B7-H4+ targets and presented antitumor activity in vivo against B7-H4+ human ovarian tumor xenografts. 

Product Details
Technical Data Sheet (pdf)

Product Details

Source
Human B7-H4 amino acids (Phe29-Ala258) (Accession # Q7Z7D3) was expressed in CHO cells.The carboxy terminus contains Fc-6His tag.
Molecular Mass
The 475 amino acid recombinant protein has a predicted molecular mass of approximately 53.0 kD. The DTT-reduced and non-reduced protein migrate at approximately 70kD and 140kD respectively by SDS-PAGE. The predicted N-terminal amino acid is Phe.
Purity
> 95% by SDS-PAGE gel as determined by Coomassie stained SDS-PAGE.
Formulation
0.22 µm filtered protein solution is in PBS pH 7.2.
Endotoxin Level
Less than 0.1 EU per µg cytokine as determined by the LAL method.
Concentration
10 and 25 µg sizes are bottled at 200 µg/mL. 100 µg size and larger sizes are lot-specific and bottled at the concentration indicated on the vial. To obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.
Storage & Handling
Unopened vial can be stored between 2°C and 8°C for up to 2 weeks, at -20°C for up to six months, or at -70°C or colder until the expiration date. For maximum results, quick spin vial prior to opening. The protein can be aliquoted and stored at -20°C or colder. Stock solutions can also be prepared at 50 - 100 µg/mL in appropriate sterile buffer, carrier protein such as 0.2 - 1% BSA or HSA can be added when preparing the stock solution. Aliquots can be stored between 2°C and 8°C for up to one week and stored at -20°C or colder for up to 3 months. Avoid repeated freeze/thaw cycles.
Activity
Human recombinant B7-H4 inhibits the anti CD3 (Cat. No. 317303)-induced proliferation of activated human T cells; the inhibitory effect was measured using Deep Blue Cell Viability™ Kit (Cat. No. 424701). The ED50 = 0.8 - 4 µg/ml.
Application

Bioassay

Application Notes

BioLegend carrier-free recombinant proteins provided in liquid format are shipped on blue-ice. Our comparison testing data indicates that when handled and stored as recommended, the liquid format has equal or better stability and shelf-life compared to commercially available lyophilized proteins after reconstitution. Our liquid proteins are verified in-house to maintain activity after shipping on blue ice and are backed by our 100% satisfaction guarantee. If you have any concerns, contact us at tech@biolegend.com.

Antigen Details

Structure
Dimer
Distribution

Antigen presenting cells (dendritic cells, peritoneal macrophages, and splenic B cells), epithelium of normal tissues breast, pancreas, and kidney, and some tumor cells derived from mammary, ovary, and uterus.

Function
B7- H4 inhibits T cell activation, proliferation, and cytokine production. B7-H4 is downregulated after B cell activation and induced by L-10 and TGF-β in peritoneal macrophages.
Interaction
Activated T cells
Bioactivity
Human recombinant B7-H4 inhibits the anti CD3-induced proliferation of activated human T cells.
Biology Area
Costimulatory Molecules, Immunology
Molecular Family
Soluble Receptors
Antigen References
  1. Prasad DV, et al. 2003. Immunity. 18:863.
  2. Zang X, et al. 2003. PNAS. 100:10388.
  3. Ou D, et al. 2006. Cell Transplant. 15:399.
  4. Azuma T, et al. 2009. PLoS Med. 6(10):e1000166.
  5. Wei J, et al. 2011. J Exp Med. 208:1683.
  6. Radichev IA, et al. 2014. Diabetes. 63:3470.
  7. Smith JB, et al. 2016. Mol Ther. 24:1987.
  8. Podojil JR, Miller SD. 2017. Immunol Rev. 276:40.
Gene ID
79679 View all products for this Gene ID
UniProt
View information about B7-H4 on UniProt.org

Related FAQs

Why choose BioLegend recombinant proteins?

     • Each lot of product is quality-tested for bioactivity as indicated on the data sheet.
     • Greater than 95% Purity or higher, tested on every lot of product.
     • 100% Satisfaction Guarantee for quality performance, stability, and consistency.
     • Ready-to-use liquid format saves time and reduces challenges associated with reconstitution.
     • Bulk and customization available. Contact us.
     • Learn more about our Recombinant Proteins.

How does the activity of your recombinant proteins compare to competitors?

We quality control each and every lot of recombinant protein. Not only do we check its bioactivity, but we also compare it against other commercially available recombinant proteins. We make sure each recombinant protein’s activity is at least as good as or better than the competition’s. In order to provide you with the best possible product, we ensure that our testing process is rigorous and thorough. If you’re curious and eager to make the switch to BioLegend recombinants, contact your sales representative today!

What is the specific activity or ED50 of my recombinant protein?

The specific activity range of the protein is indicated on the product datasheets. Because the exact activity values on a per unit basis can largely fluctuate depending on a number of factors, including the nature of the assay, cell density, age of cells/passage number, culture media used, and end user technique, the specific activity is best defined as a range and we guarantee the specific activity of all our lots will be within the range indicated on the datasheet. Please note this only applies to recombinants labeled for use in bioassays. ELISA standard recombinant proteins are not recommended for bioassay usage as they are not tested for these applications.

Have your recombinants been tested for stability?

Our testing shows that the recombinant proteins are able to withstand room temperature for a week without losing activity. In addition the recombinant proteins were also found to withstand four cycles of freeze and thaw without losing activity.

Does specific activity of a recombinant protein vary between lots?

Specific activity will vary for each lot and for the type of experiment that is done to validate it, but all passed lots will have activity within the established ED50 range for the product and we guarantee that our products will have lot-to-lot consistency. Please conduct an experiment-specific validation to find the optimal ED50 for your system.

How do you convert activity as an ED50 in ng/ml to a specific activity in Units/mg?

Use formula Specific activity (Units/mg) = 10^6/ ED50 (ng/mL)

Go To Top Version: 1    Revision Date: 06.27.2018

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account